These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18768567)

  • 21. Are drug eluting stents really worth the money?
    Thomas M
    Heart; 2006 Jan; 92(1):5-7. PubMed ID: 15939723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting stents are here--now what? Implications for clinical practice and health care costs.
    Hirshfeld JW; Wilensky RL
    Cleve Clin J Med; 2004 Oct; 71(10):825-8. PubMed ID: 15529488
    [No Abstract]   [Full Text] [Related]  

  • 23. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stent choice and the hidden consequences of cost savings.
    Cavender MA; Ellis SG
    Nat Rev Cardiol; 2012 Oct; 9(10):559-60. PubMed ID: 22922596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?
    Garg S; Duckers HJ; Serruys PW
    Eur Heart J; 2010 May; 31(9):1032-5. PubMed ID: 20064819
    [No Abstract]   [Full Text] [Related]  

  • 27. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
    Jimenez-Valero S; Moreno R; Sanchez-Recalde A; Galeote G; Calvo L; Viana A; Lopez de Sá E; López-Sendón J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):137-46. PubMed ID: 19124417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response.
    Li JJ; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):732-5. PubMed ID: 19323943
    [No Abstract]   [Full Text] [Related]  

  • 31. Newer stents: looking at the horizon.
    Ramcharitar S; Serruys PW
    Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
    Jähne J; Schirren J
    Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-restenosis study on a new drug eluting stent].
    Zhao A; Zhang H; Huang N; Zhang B; Yang K; Li Z; Zhao H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):856-9, 878. PubMed ID: 18788296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The drug-eluting stent saga.
    Windecker S; Jüni P
    Circulation; 2009 Feb; 119(5):653-6. PubMed ID: 19204314
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
    J Am Coll Cardiol; 2009 Mar; 53(9):812-3. PubMed ID: 19245976
    [No Abstract]   [Full Text] [Related]  

  • 37. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug eluting stents: maximising benefit and minimising cost.
    Gunn J; Morton AC; Wales C; Newman CM; Crossman DC; Cumberland DC
    Heart; 2003 Feb; 89(2):127-31. PubMed ID: 12527654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.
    Bittl JA
    J Am Coll Cardiol; 2009 Mar; 53(11):929-30. PubMed ID: 19281921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.